XENOTRANSPLANTATION: THE END OF ORGAN SHORTAGE? │ EP94

Welcome to the Atomic Anesthesia podcast hosted by CRNA professor Dr. Rhea Temmermand and Co-Founder Sachi Lord. On this show, you'll hear clear, clinically grounded discussions designed for nurse anesthesia residents and CRNAs who want to feel more confident in complex pharmacology, physiology, and real-world anesthesia decision-making.

Want more content like this? Become a member of our learning platform.

⚠️ SIGN UP FOR OUR FREE NEWSLETTER: [NEWSLETTER SIGN-UP]

In this episode:

• Xenotransplantation is becoming clinically real, using genetic engineering to allow pig organs to function in humans
• Recent cases, including 271 days of pig kidney support, show potential as a bridge to human transplant
• Key challenges include chronic rejection, coagulation mismatch, and evolving immunosuppression
• For anesthesia, these patients bring unstable physiology, unpredictable hemodynamics, and increasing clinical relevance

💜 LIVE WEBINAR: Save your seat on our monthly, free webinars. Replays are sent to your inbox and you get access to all of our previous webinars.

[WEBINAR SIGN UP]

💜 FREE DOWNLOADS: Grab your copy of customized study plans & worksheets.

[SEE/NCE STUDY PLAN]

[RN ICU DRUG CHART]

💜 CONNECT: 📥 Email questions, comments or topic suggestions to Dr. Temmermand at [email protected], follow us on social media, and sign up for our newsletter.

[NEWSLETTER SIGN-UP]

[INSTAGRAM] [TIKTOK] [YOUTUBE]

Mentioned in this episode:

💜 PARTNERS: The Incomologists®

https://theincomologists.com/ You work hard caring for others—let us take care of you. Whether you’re a W-2 employee or transitioning to a 1099 role, we understand the unique challenges healthcare professionals face, from insurance coverage to financial planning. That’s where we step in. Like you, we are a team of healthcare providers who understand your needs and help you find tailored insurance plans and financial strategies without the hassle or pressure. And we’re a partner you can rely on, today and in the future. We evaluate all available options and resources in the market to protect our clients, so contact us, and we’ll get started! - Jake Bevilacqua, CRNA ([email protected])